Zobrazeno 1 - 10
of 11
pro vyhledávání: '"İsmail Akçok"'
© 2022, The Author(s), under exclusive licence to Springer Nature B.V.Background: Despite the recent advances in chemotherapy, the outcomes and the success of these treatments still remain insufficient. Novel combination treatments and treatment str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e507540edbd69fbf234c55b7a26136
https://avesis.kayseri.edu.tr/publication/details/7fad3399-5939-46a0-b949-10b63cfb464f/oai
https://avesis.kayseri.edu.tr/publication/details/7fad3399-5939-46a0-b949-10b63cfb464f/oai
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 155
Drug discovery has a 90% rate of failure because preclinical platforms for drug testing do not mimic the in vivo conditions. Doxorubicin (DOX) is a commonly used drug to treat breast cancer patients even though it has side effects. Lab-on-a-chip (LOC
Autor:
Arnaud Magrez, Aswin Gopakumar, Florian Le Formal, Loris Lombardo, Ismail Akçok, Paul J. Dyson, Kevin Sivula
Publikováno v:
ChemistrySelect. 3:10271-10276
Publikováno v:
European journal of medicinal chemistry. 180
Cytotoxic effects of (R)-4'-methylklavuzon were investigated on hepatocellular carcinoma cells (HuH-7 and HepG2) and HuH-7 EpCAM
Cytotoxic effects of (R)-4'-methylklavuzon were investigated on hepatocellular carcinoma cells (HuH-7 and HepG2) and HuH-7 EpCAM(+)/CD133(+) cancer stem cells. IC50 of (R)-4'-methylklavuzon was found as 1.25 mu M for HuH-7 parental cells while it was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d344e8ec838c2b5954ab0ba7112d9376
https://aperta.ulakbim.gov.tr/record/74491
https://aperta.ulakbim.gov.tr/record/74491
Autor:
Aylin Alkan, İsmail Akçok, Ayhan Şen, Hasan Ozan Otaş, Ali Cagir, Meltem Kutluer, Tuğçe Kanbur, Murat Delman, Murat Kara
Publikováno v:
Bioorganicmedicinal chemistry. 25(16)
Klavuzons are 6-(naphthalen-1-yl) substituted 5,6-dihydro-2H-pyran-2-one derivatives showing promising antiproliferative activities in variety of cancer cell lines. In this work, racemic syntheses of nine novel 4′-alkyl substituted klavuzon derivat
Publikováno v:
Bioorganic chemistry. 71
Klavuzon is a naphthalen-1-yl substituted α,β-unsaturated δ-lactone derivative, and is one of the anti-proliferative members of this class of compounds. Asymmetric and racemic syntheses of novel α,β-unsaturated δ-lactone derivatives are importa
WOS: 000424633600005
PubMed ID: 28554313
Aims: In this study, discovery of novel anticancer agents acting by more than one mechanism was aimed. Method: For this purpose, eleven previously synthesized simple-stilbene, chalcone, flavanone der
PubMed ID: 28554313
Aims: In this study, discovery of novel anticancer agents acting by more than one mechanism was aimed. Method: For this purpose, eleven previously synthesized simple-stilbene, chalcone, flavanone der
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03621e380290fa92b0f1c9ec1cc2574
https://aperta.ulakbim.gov.tr/record/50229
https://aperta.ulakbim.gov.tr/record/50229
Autor:
Aswin Gopakumar, Bastien L. Roulier, Sergey A. Katsyuba, Alena Karakulina, Thomas LaGrange, Shoubhik Das, İsmail Akçok, Paul J. Dyson
Publikováno v:
ChemInform. 47
We describe a catalytic system composed of rhodium nanoparticles immobilized in a Lewis acidic ionic liquid. The combined system catalyzes the hydrogenation of quinolines, pyridines, benzofurans, and furan to access the corresponding heterocycles, im
Autor:
İsmail Akçok, Ali Cagir
Publikováno v:
ChemInform. 46
We described a one-pot vinylogous aldol addition of methyl 3-butenoate to aromatic aldehydes in the presence of silver salts and the TMSCl–TBAF mixture. The reaction can be done simply by sequentially mixing reagents in situ, and it does not requir